Re: Interesting read on the backlash to FDA's approval of aducanumab

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Prev Message Back To Forum Threaded View Next Message

tada

Rank: President [?]

Points: 7750 [?]

Votes: 40 Score: 3.4 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Interesting read on the backlash to FDA's approval of aducanumab

in response to

Re: Interesting read on the backlash to FDA's approval of aducanumab

tada

posted on Jun 10, 2021 08:47PM

Follow-up to the last post. The increase in the share price of BIIB is very telling that the world really wants a drug that will help ease the burden of Alzheimer's. With BIIB going up $16 billion on this news, the cardio market potentially worth $10 billion for ABL and a positive COVID trial potentially giving us a $4 billion market for that therapy, we could potentially be sitting on a $30 billion market cap company. In reality though it sometimes seems like it's just a pile of dung.